IL22 and graft versus host disease: By contrast, the MSCs-exo-treated group presented significantly lower levels of IL-17A (Fig. 5e), the typical cytokine produced by Th17 cells; IL-22 (Fig. 5g); and IL-21 (Fig. 5f), which has an essential role in all phases of GVHD pathophysiology to mediate tissue damage.